OLIVIA DUROCHER-DUCATTE: Open Payments
NPI 1366286767 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,674 in 148 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,235 · 2025 $2,674
Food & beverage: $2,674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $476 |
| AstraZeneca Pharmaceuticals LP | 18 | $358 |
| Novo Nordisk Inc | 17 | $345 |
| PFIZER INC. | 12 | $209 |
| GlaxoSmithKline, LLC. | 11 | $192 |
| Otsuka America Pharmaceutical, Inc. | 14 | $182 |
| Axsome Therapeutics, Inc. | 11 | $166 |
| Amgen Inc. | 11 | $153 |
| Lilly USA, LLC | 7 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
Products named: QULIPTA, TRELEGY ELLIPTA, REXULTI, AIRSUPRA, Auvelity, Ozempic, FARXIGA, Rybelsus.
Industry payments across NY — which companies pay providers there.
